Funding for this research was provided by:
Hartstichting (2020B006 CAPACITY)
ZonMW (DEFENCE 10430102110006)
EuroQol Research Foundation
Novartis Global
Sanofi Genzyme
Novo Nordisk
Servier
Daiichi-Sankyo
Article History
Accepted: 24 February 2022
First Online: 9 March 2022
Conflict of interest
: T.A. Klamer, M. Linschoten and F.W. Asselbergs declare that they have no competing interests.